BCM
PACB icon

Bayesian Capital Management’s Pacific Biosciences PACB Stock Holding History

Bayesian Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-213,900
Closed -$364K – 905
2024
Q3 		$364K Buy
+213,900
New +$351K 0.04% 434
2023
Q3 		– Sell
-10,836
Closed -$144K – 909
2023
Q2 		$144K Buy
+10,836
New +$132K 0.02% 670
2019
Q2 		– Sell
-16,900
Closed -$122K – 647
2019
Q1 		$122K Sell
16,900
-16,994
-50% -$123K 0.02% 501
2018
Q4 		$251K Buy
+33,894
New +$215K 0.05% 461
2017
Q4 		– Sell
-10,200
Closed -$54K – 677
2017
Q3 		$54K Buy
+10,200
New +$43.8K 0.01% 458
2016
Q4 		– Sell
-31,510
Closed -$282K – 675
2016
Q3 		$282K Buy
31,510
+14,710
+88% +$123K 0.19% 209
2016
Q2 		$118K Buy
+16,800
New +$153K 0.07% 356

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return